AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Gliheart-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Cue Labs

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gliheart-M1 Tablet SR

Diabeticard Duo is a dual-action antidiabetic medication, prescribed for adult patients with type 2 diabetes. This combined formulation helps manage blood glucose levels. Diabeticard Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar readings. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like kidney disease, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive treatment plan involving a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle adjustments are critical for diabetes control. The most prevalent side effect is hypoglycemia (low blood sugar). Learn to recognize symptoms—sweating, dizziness, headache, trembling—and know how to counteract them. Maintain regular mealtimes and always carry a readily available glucose source, such as candy or juice. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a potential side effect. This medication is contraindicated for those with type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Individuals with a history of heart conditions should inform their doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood sugar monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Gliheart-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Gliheart-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Gliheart-M1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Gliheart-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliheart-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Gliheart-M1 Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Gliheart-M1 Tablet SR works:

Gliheart-M1 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliheart-M1 Tablet SR and alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliheart-M1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Gliheart-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliheart-M1 Tablet SR cautiously, potentially requiring dose modification under medical supervision. The medication is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, Gliheart-M1 Tablet SR requires careful administration. Dosage modification of Gliheart-M1 Tablet SR might be necessary. Physician consultation is advised. In patients experiencing mild to moderate liver disease, Gliheart-M1 Tablet SR is typically initiated at a low dosage; however, it's contraindicated in those with severe hepatic dysfunction.

What if you forget to take Gliheart-M1 Tablet SR :

Should you forget a Gliheart-M1 Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliheart-M1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliheart-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Gliheart-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Gliheart-M1 Tablet SR and seek immediate medical attention.
Gliheart-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Gliheart-M1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gliheart-M1 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Yes, Gliheart-M1 Tablet SR can lower your blood sugar (causing hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a rapid heartbeat, and shakiness or anxiety. This is more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Gliheart-M1 Tablet SR and alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Gliheart-M1 Tablet SR
47
MRP 57
17% off